| P50 | author | Alexandre de Titta | Q82913117 |
| | Jeffrey A. Hubbell | Q42863795 |
| P2093 | author name string | Melody A Swartz | |
| | Stephan Kontos | |
| | Sachiko Hirosue | |
| | Iraklis C Kourtis | |
| | Toon Stegmann | |
| P2860 | cites work | Beta Regression in R | Q57263816 |
| | CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions | Q80444912 |
| | Exploiting lymphatic transport and complement activation in nanoparticle vaccines | Q81305052 |
| | Nanoparticle conjugation and pulmonary delivery enhance the protective efficacy of Ag85B and CpG against tuberculosis | Q84592120 |
| | Strategies in the design of nanoparticles for therapeutic applications | Q37771241 |
| | Myeloid-Derived Suppressor Cells in Human Cancer | Q37778697 |
| | Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns | Q37800358 |
| | Virosome: a novel vector to enable multi-modal strategies for cancer therapy | Q37858677 |
| | Decisions about dendritic cells: past, present, and future | Q37963951 |
| | Long-term tracking of cells using inorganic nanoparticles as contrast agents: are we there yet? | Q37987866 |
| | Toxicity testing of nanomaterials | Q37995926 |
| | Effect of core diameter, surface coating, and PEG chain length on the biodistribution of persistent luminescence nanoparticles in mice | Q39598440 |
| | Induction of lymphoidlike stroma and immune escape by tumors that express the chemokine CCL21. | Q39722616 |
| | Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity | Q40013431 |
| | Subcapsular sinus macrophages in lymph nodes clear lymph-borne viruses and present them to antiviral B cells | Q40068378 |
| | Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. | Q40827632 |
| | Conduits mediate transport of low-molecular-weight antigen to lymph node follicles | Q41291427 |
| | Subcapsular sinus macrophages prevent CNS invasion on peripheral infection with a neurotropic virus. | Q41485418 |
| | Synapse-directed delivery of immunomodulators using T-cell-conjugated nanoparticles | Q42234959 |
| | Antigen delivery to dendritic cells by poly(propylene sulfide) nanoparticles with disulfide conjugated peptides: Cross-presentation and T cell activation | Q42863719 |
| | In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles. | Q44490370 |
| | Nanoparticles target distinct dendritic cell populations according to their size | Q45732404 |
| | Subcapsular encounter and complement-dependent transport of immune complexes by lymph node B cells. | Q46017170 |
| | Distinct polymer architecture mediates switching of complement activation pathways at the nanosphere-serum interface: implications for stealth nanoparticle engineering | Q47348681 |
| | Myeloid-derived suppressor cells: linking inflammation and cancer | Q24641811 |
| | Identification of splenic reservoir monocytes and their deployment to inflammatory sites | Q24649151 |
| | Myeloid-derived suppressor cells as regulators of the immune system | Q28131637 |
| | Structure and function of the spleen | Q28264813 |
| | Lymph node fibroblastic reticular cells construct the stromal reticulum via contact with lymphocytes | Q28590628 |
| | Nanoparticle therapeutics: an emerging treatment modality for cancer | Q29615628 |
| | Monocyte recruitment during infection and inflammation | Q29620067 |
| | Utility of virosomal adjuvated influenza vaccines: a review of the literature | Q30393876 |
| | Programming the magnitude and persistence of antibody responses with innate immunity | Q30400144 |
| | Microneedle and mucosal delivery of influenza vaccines | Q30418015 |
| | In vivo tumor cell targeting with "click" nanoparticles | Q33350022 |
| | Synthesis of pyridyl disulfide-functionalized nanoparticles for conjugating thiol-containing small molecules, peptides, and proteins | Q33549781 |
| | CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo. | Q33928441 |
| | Functions of myeloid and lymphoid dendritic cells. | Q33936523 |
| | Therapeutic cell engineering with surface-conjugated synthetic nanoparticles | Q34112602 |
| | Multi-stage delivery nano-particle systems for therapeutic applications | Q34166491 |
| | Epidermal viral immunity induced by CD8alpha+ dendritic cells but not by Langerhans cells | Q34265522 |
| | Tissue-penetrating delivery of compounds and nanoparticles into tumors | Q35016106 |
| | The C-type lectin SIGN-R1 mediates uptake of the capsular polysaccharide of Streptococcus pneumoniae in the marginal zone of mouse spleen. | Q35122158 |
| | In situ engineering of the lymph node microenvironment via intranodal injection of adjuvant-releasing polymer particles | Q35229225 |
| | DC mobilization from the skin requires docking to immobilized CCL21 on lymphatic endothelium and intralymphatic crawling | Q35237489 |
| | Nanoparticle conjugation of antigen enhances cytotoxic T-cell responses in pulmonary vaccination | Q35518723 |
| | Therapeutic siRNA silencing in inflammatory monocytes in mice | Q35539710 |
| | Chemokines control naive CD8+ T cell selection of optimal lymph node antigen presenting cells. | Q35669056 |
| | Dendritic cell-mediated T cell polarization | Q35988802 |
| | Capture of influenza by medullary dendritic cells via SIGN-R1 is essential for humoral immunity in draining lymph nodes | Q36178920 |
| | Impaired humoral immunity and tolerance in K14-VEGFR-3-Ig mice that lack dermal lymphatic drainage | Q36179447 |
| | Dendritic cells in a mature age. | Q36475977 |
| | Targeting dendritic cells with biomaterials: developing the next generation of vaccines | Q36627404 |
| | Dendritic cells: understanding immunogenicity | Q36986703 |
| | Fluorescent pegylated nanoparticles demonstrate fluid-phase pinocytosis by macrophages in mouse atherosclerotic lesions | Q37170756 |
| | Virus-like particle (VLP) lymphatic trafficking and immune response generation after immunization by different routes | Q37279007 |
| | Intradermal, epidermal and transcutaneous vaccination: from immunology to clinical practice | Q37290106 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | nanoparticle | Q61231 |
| P304 | page(s) | e61646 | |
| P577 | publication date | 2013-04-23 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Peripherally administered nanoparticles target monocytic myeloid cells, secondary lymphoid organs and tumors in mice | |
| P478 | volume | 8 | |